captopril has been researched along with etc-1002 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahmed, AA; Ahmed, AAE; El Morsy, EM; Mohamed, SK; Nofal, S | 2 |
2 other study(ies) available for captopril and etc-1002
| Article | Year |
|---|---|
Effect of bempedoic acid on angiotensin-II induced hypertension and vascular tissue remodelling in renal hypertensive rats through AMPK multiple signalling pathways modulation.
Topics: AMP-Activated Protein Kinases; Angiotensin II; Animals; Blood Pressure; Captopril; Hypertension; Male; Rats; Rats, Sprague-Dawley; Vascular Remodeling | 2023 |
Targeting the adenosine monophosphate-activated protein kinase signalling pathway by bempedoic acid attenuates Angiotensin II-induced cardiac remodelling in renovascular hypertension in rats.
Topics: AMP-Activated Protein Kinases; Angiotensin II; Animals; Captopril; Hypertension; Hypertension, Renovascular; Male; Rats; Rats, Sprague-Dawley; Transforming Growth Factor beta; Ventricular Remodeling | 2023 |